Skip to main content
AmigoFish

Retatrutide Just Reached Bariatric Surgery Results

From On The Pen GLP-1 News · · 48 min

This plays from the publisher's own server. We do not host a copy.

Open at the source

Not rated yet

Description

Dave sits down with nurse practitioner and former Retatrutide clinical trial participant David White to break down the biggest obesity headlines from the 2026 American Diabetes Association Conference. Together, they explore the latest data on Retatrutide's potential to deliver bariatric surgery-level weight loss, improve cardiometabolic health, and reshape the future of obesity and type 2 diabetes treatment.

otplinks.com

Back to On The Pen GLP-1 News · Report a problem